Back to MetLife Investment Management, LLC MetLife Investment Management, LLC

VIVOVIVO

Showing 0 of 17 quarters

Position history for MetLife Investment Management, LLCMetLife Investment Management, LLC's holdings in MERIDIAN BIOSCIENCE INC

As of its Q4 2022 13F, MetLife Investment Management held 23,227 shares of VIVO (Meridian Bioscience), worth $771,369. MetLife Investment Management's 13F filings listed VIVO from Q1 2019 to Q4 2022, 16 quarterly filings.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used